| Katherine Hays, MD | |
|
3500 Healthplex Pkwy Ste 200, Norman, OK 73072-9801 | |
| (405) 515-2222 | |
| (405) 307-5618 |
| Full Name | Katherine Hays |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 15 Years |
| Location | 3500 Healthplex Pkwy Ste 200, Norman, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063432821 | NPI | - | NPPES |
| 200059050A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 23459 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norman Regional | Norman, OK | Hospital |
| O U Medical Center | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Norman Regional Providers Specialty Care | 5496900706 | 138 |
News Archive
For patients with advanced leukemia, access to high-quality end-of-life care appears to be reduced in those dependent on blood transfusions, according to a new study being presented during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta.
Genentech, a member of the Roche Group, announced today that a pivotal Phase II study with vismodegib showed positive results in people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
Milk is designed by nature as a complete food. Its composition has evolved with each mammalian species to reflect the particular environmental conditions and evolutionary demands of the young of that species. Humans have exploited this valuable resource since the dawn of the agricultural revolution through domestication of animals, in particular the cow. We have developed the technology to preserve milk during times of abundance and this has resulted in an array of foods now common in the diets of most human cultures.
Deloitte today is announcing the upcoming release of PopulationMiner, a real-world, data-analytics solution for gleaning insights and relationships among drugs and diseases across broad patient populations over time and spanning multiple therapeutic and clinical areas.
Researchers from the Institute of Neurosciences of the UB and from IDIBAPS together with a team from the University Pierre and Marie Curie and the Institute du Fer à Moulin, published a study in Nature Communications, which demonstrates that the regulation in Pyk2, a protein-tyrosine kinase, causes alterations of the synaptic plasticity involved in memory tasks, associated with the hippocampus in mouse models of neurodegenerative diseases, such as Huntington's.
› Verified 2 days ago
| Entity Name | Nrhs Physician Office Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780904953 PECOS PAC ID: 3375732035 Enrollment ID: O20110111000514 |
News Archive
For patients with advanced leukemia, access to high-quality end-of-life care appears to be reduced in those dependent on blood transfusions, according to a new study being presented during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta.
Genentech, a member of the Roche Group, announced today that a pivotal Phase II study with vismodegib showed positive results in people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
Milk is designed by nature as a complete food. Its composition has evolved with each mammalian species to reflect the particular environmental conditions and evolutionary demands of the young of that species. Humans have exploited this valuable resource since the dawn of the agricultural revolution through domestication of animals, in particular the cow. We have developed the technology to preserve milk during times of abundance and this has resulted in an array of foods now common in the diets of most human cultures.
Deloitte today is announcing the upcoming release of PopulationMiner, a real-world, data-analytics solution for gleaning insights and relationships among drugs and diseases across broad patient populations over time and spanning multiple therapeutic and clinical areas.
Researchers from the Institute of Neurosciences of the UB and from IDIBAPS together with a team from the University Pierre and Marie Curie and the Institute du Fer à Moulin, published a study in Nature Communications, which demonstrates that the regulation in Pyk2, a protein-tyrosine kinase, causes alterations of the synaptic plasticity involved in memory tasks, associated with the hippocampus in mouse models of neurodegenerative diseases, such as Huntington's.
› Verified 2 days ago
| Entity Name | Norman Regional Providers Specialty Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548513773 PECOS PAC ID: 5496900706 Enrollment ID: O20130312000200 |
News Archive
For patients with advanced leukemia, access to high-quality end-of-life care appears to be reduced in those dependent on blood transfusions, according to a new study being presented during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta.
Genentech, a member of the Roche Group, announced today that a pivotal Phase II study with vismodegib showed positive results in people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
Milk is designed by nature as a complete food. Its composition has evolved with each mammalian species to reflect the particular environmental conditions and evolutionary demands of the young of that species. Humans have exploited this valuable resource since the dawn of the agricultural revolution through domestication of animals, in particular the cow. We have developed the technology to preserve milk during times of abundance and this has resulted in an array of foods now common in the diets of most human cultures.
Deloitte today is announcing the upcoming release of PopulationMiner, a real-world, data-analytics solution for gleaning insights and relationships among drugs and diseases across broad patient populations over time and spanning multiple therapeutic and clinical areas.
Researchers from the Institute of Neurosciences of the UB and from IDIBAPS together with a team from the University Pierre and Marie Curie and the Institute du Fer à Moulin, published a study in Nature Communications, which demonstrates that the regulation in Pyk2, a protein-tyrosine kinase, causes alterations of the synaptic plasticity involved in memory tasks, associated with the hippocampus in mouse models of neurodegenerative diseases, such as Huntington's.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Hays, MD 3500 Healthplex Pkwy Ste 200, Norman, OK 73072-9801 Ph: (405) 515-2222 | Katherine Hays, MD 3500 Healthplex Pkwy Ste 200, Norman, OK 73072-9801 Ph: (405) 515-2222 |
News Archive
For patients with advanced leukemia, access to high-quality end-of-life care appears to be reduced in those dependent on blood transfusions, according to a new study being presented during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta.
Genentech, a member of the Roche Group, announced today that a pivotal Phase II study with vismodegib showed positive results in people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
Milk is designed by nature as a complete food. Its composition has evolved with each mammalian species to reflect the particular environmental conditions and evolutionary demands of the young of that species. Humans have exploited this valuable resource since the dawn of the agricultural revolution through domestication of animals, in particular the cow. We have developed the technology to preserve milk during times of abundance and this has resulted in an array of foods now common in the diets of most human cultures.
Deloitte today is announcing the upcoming release of PopulationMiner, a real-world, data-analytics solution for gleaning insights and relationships among drugs and diseases across broad patient populations over time and spanning multiple therapeutic and clinical areas.
Researchers from the Institute of Neurosciences of the UB and from IDIBAPS together with a team from the University Pierre and Marie Curie and the Institute du Fer à Moulin, published a study in Nature Communications, which demonstrates that the regulation in Pyk2, a protein-tyrosine kinase, causes alterations of the synaptic plasticity involved in memory tasks, associated with the hippocampus in mouse models of neurodegenerative diseases, such as Huntington's.
› Verified 2 days ago
Justin Elliot Fields, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 950 N Porter, Suite 300, Norman, OK 73071 Phone: 405-329-0121 Fax: 405-292-6099 | |
Sunil Thomas Mathew, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3500 Healthplex Pkwy Ste 200, Norman, OK 73072 Phone: 405-515-2222 Fax: 405-515-2208 | |
Aaron Lee Boyd, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 650 24th Ave Sw, Suite 110, Norman, OK 73069 Phone: 405-307-5337 Fax: 405-253-4148 | |
Archana Gautam, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3500 Healthplex Pkwy, Suite 200, Norman, OK 73072 Phone: 405-515-2222 Fax: 405-307-5617 | |
Philip C Bird, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1125 N Porter Ave, Norman, OK 73071 Phone: 405-360-2777 Fax: 405-360-2780 | |
Robert Michael Holbrook, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1515 N Porter Ave, Suite 200, Norman, OK 73071 Phone: 405-366-8619 Fax: 405-366-1839 |